VEEV Revenue Growth (YoY) Analysis

Revenue growth (YoY) of 16.3% is the percentage increase in the company's total sales compared to the same period one year ago, so it shows how quickly the business is expanding its top line.

This level places the company at the 79th percentile among Healthcare sector peers, well above the sector median of 7.4%, meaning its current growth exceeds most comparable firms. However, the trend information is unavailable: the year-over-year change and quarter-over-quarter change are both marked N/A, so there is no evidence whether this growth rate is accelerating or decelerating. Because the current growth is strong but the direction is unknown, the investment risk is elevated compared to a stock with a clear upward trend, though the high level alone still offers a potential opportunity. The level supports a positive view, but the missing trend data prevents confidence in its sustainability. This metric partially supports the NEUTRAL verdict — the strong absolute growth justifies not being bearish, while the lack of trend data argues against a bullish stance.

Frequently Asked Questions

Closest Sector Peers